Catalyst Wire Dossier Catalyst Wire Dossier

Eksunbi

ustekinumab · Samsung Bioepis NL B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eksunbi, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: EMA Withdrawn: Eksunbi (ustekinumab) — Samsung Bioepis NL B.V.

See pricing